Skip to content

Extrapolation of Prevalence Rate of Psoriasis to Countries and Regions:

Extrapolation of Prevalence Rate of Psoriasis to Countries and Regions: The following table attempts to extrapolate the above prevalence rate for Psoriasis to the populations of various countries and regions. The national prevalence rate of HCV antibody positivity has been estimated to be between 10 and 13 per cent of the entire population (8). In relation to the high percentage of parental consanguinity, the MENA region may face a higher risk factor for familial multiple sclerosis (FMS) throughout inbred communities. These countries are Bahrain, Egypt, Kuwait, Oman, Saudi Arabia and United Arab Emirates. Although autoimmune clinical data are extrapolated to the population of the MENA region, clinical trials performed locally can provide a more useful source of clinical data on efficacy and tolerability to the drug in the local population. The problems with health care for psoriasis patients in Ukraine are not unique – similar problems are more or less applicable to other countries of Eastern-European region.

Extrapolation of Prevalence Rate of Psoriasis to Countries and Regions: 2Eloss of skin tissue, Limited access to the lesion if it is deep withinthe skin and a high rate of recurrence of the skin cancer. Psoriasis treatment. Database records include the population, the geographic region, the relative publication and a number of epidemiological indices like incidence, prevalence, mortality, morbidity, age at onset etc. It is a treemap representing the incidence rates of autoimmune diseases over populations, with each rectangle representing the specific incidence rate of an autoimmune disease for a specific population. The colour scale, corresponding to each country, depends on the screened data and reflects the value of the selected index for the specified disease and population. Except their potential to increase our basic knowledge by observation and extrapolation such data initiate new fields and contexts for researchers of autoimmune physiology, genetics and therapeutics as much as physicians, health professionals and policymakers. Indeed, in country-specific studies, the estimated prevalence of psoriasis ranges from 0 in Australian Aborigines and Andean Indians to 11. If we assume that there is a similar prevalence in Portugal, it can be extrapolated that approximately 637,000 800,000 individuals are affected with psoriasis in these two Iberian countries. In these regions, dermatologists with a recognized interest in the treatment of psoriasis were then invited to participate in the study; of the 577 dermatologists invited to participate, 245 did not meet the criteria for participation in the study (for example, too few patients or the patients did not have psoriasis of at least moderate severity).

Treatment modalities of chronic plaque psoriasis have dramatically changed over the past ten years with a still continuing shift from inpatient to outpatient treatment. Such analyses performed in the Angloamerican context mostly concentrated on cost efficiency of different outpatient alternatives 5,17 19, as inpatient therapy does not play a major role in these regions. Heart failure (HF), often referred to as congestive heart failure (CHF), occurs when the heart is unable to pump sufficiently to maintain blood flow to meet the body’s needs. Common respiratory signs are increased rate of breathing and increased work of breathing (non-specific signs of respiratory distress). The prevalence and incidence of heart failure are increasing, mostly because of increasing life span, but also because of increased prevalence of risk factors (hypertension, diabetes, dyslipidemia, and obesity) and improved survival rates from other types of cardiovascular disease (myocardial infarction, valvular disease, and arrhythmias).

Skin Cancer Frequently Asked Questions

Plos One: Cost-of-illness In Psoriasis: Comparing Inpatient And Outpatient Therapy